Surgical treatment of patients with multiple carcinomas
Witold Knast, Marta Strutyńska-Karpińska, Jerzy RabczyńskiMed Sci Monit 2001; 7(6): CR1256-1262 :: ID: 508236
Abstract
Background: Primary multiple carcinomas are not observed very frequently. Research has been focused mainly on such issues as the frequency of occurrence of primary multiple carcinomas, the identification of high-risk groups, early diagnosis, treatment methods, and prognosis. The purpose of this article is to present our own experience in the surgical treatment of patients with multiple cancers.
Material and methods: The paper presents 13 patients of both sexes with primary multiple carcinomas. Four of these patients were diagnosed with synchronous carcinomas, the remaining patients with metachronous. The malignant tumors were variously localized. In the group with synchronous carcinomas, the malignant tumors were located in esophagus, stomach and rectum, pancreas and right ovary, esophagus and palatine tonsil. In the group with metachronous carcinomas, another cancer was diagnosed 12 months to 24 years after the treatment of the first carcinoma was completed. The other cancers were located in esophagus, stomach, pancreas, lung, and the skin of the cheek. Nine patients were qualified for surgical treatment on the basis of the preoperative TNM classification. Various surgical procedures were used. In cases of synchronous multiple carcinomas one-stage operations were preferred.
Results: Significant postoperative complications were noted in 2 cases. In the first case, a recto-sigmoid anastomotic leak resulted in increased circulatory and renal insufficiency, leading to the patient’s decease. In the second case, a massive gastric hemorrhage after ileocoloesophagoplasty led to respiratory insufficiency, which was the cause of the patient’s decease. Two patients died within 12 months after surgical treatment. In the first case cancer recurrence was the cause of death; in the second, myocardial infarction. Long-term follow-up was focused on 5 patients with no cancer recurrence during the period from 12 months to 4 years after surgical treatment.
Conclusion: The results of this study suggest that patients who have had a first cancer successfully treated are at higher risk of developing a subsequent cancer, and that regular follow-up with thorough examination in patients successfully treated for cancer may lead to the early detection of a subsequent cancer when it is still at a curable stage.
Keywords: multiple carcinomas, synchronous carcinomas, metachronous carcinomas
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952